Advanced search
Publication Cover
Future Medicinal Chemistry Volume 2, 2010 - Issue 12
Submit an article Journal homepage
144
Views
0
CrossRef citations to date
0
Altmetric
Research Article

SSAO Substrates Exhibiting Insulin-Like Effects in Adipocytes as a Promising Treatment Option for Metabolic Disorders

Josep Mercader1 Institut National de la Santé et de la Recherche Médicale, INSERM U858 équipe 3, Université Paul Sabatier, IFR150, Centre Hospitalier Universitaire de Rangueil, 31432 Toulouse cedex 4, BP84225, FranceView further author information
,
Zsuzsa Iffiú-Soltesz1 Institut National de la Santé et de la Recherche Médicale, INSERM U858 équipe 3, Université Paul Sabatier, IFR150, Centre Hospitalier Universitaire de Rangueil, 31432 Toulouse cedex 4, BP84225, FranceView further author information
,
Xavier Brenachot1 Institut National de la Santé et de la Recherche Médicale, INSERM U858 équipe 3, Université Paul Sabatier, IFR150, Centre Hospitalier Universitaire de Rangueil, 31432 Toulouse cedex 4, BP84225, FranceView further author information
,
Ágota Földi2 Department of Organic Chemistry, Semmelweis University, Högyes Endre utca 7, H-1092Budapest, HungaryView further author information
,
Petra Dunkel2 Department of Organic Chemistry, Semmelweis University, Högyes Endre utca 7, H-1092Budapest, HungaryView further author information
,
Balázs Balogh2 Department of Organic Chemistry, Semmelweis University, Högyes Endre utca 7, H-1092Budapest, HungaryView further author information
,
Camille Attané1 Institut National de la Santé et de la Recherche Médicale, INSERM U858 équipe 3, Université Paul Sabatier, IFR150, Centre Hospitalier Universitaire de Rangueil, 31432 Toulouse cedex 4, BP84225, FranceView further author information
,
Philippe Valet1 Institut National de la Santé et de la Recherche Médicale, INSERM U858 équipe 3, Université Paul Sabatier, IFR150, Centre Hospitalier Universitaire de Rangueil, 31432 Toulouse cedex 4, BP84225, FranceView further author information
,
Péter Mátyus2 Department of Organic Chemistry, Semmelweis University, Högyes Endre utca 7, H-1092Budapest, HungaryView further author information
&
Christian Carpéné1 Institut National de la Santé et de la Recherche Médicale, INSERM U858 équipe 3, Université Paul Sabatier, IFR150, Centre Hospitalier Universitaire de Rangueil, 31432 Toulouse cedex 4, BP84225, FranceCorrespondence[email protected]
View further author information
 show all
Pages 1735-1749 | Published online: 07 Dec 2010

Bibliography

  • Medda R , BellelliA, PecP, FedericoR, ConaA, FlorisG. Copper amine oxidases from plants. In: Copper Amine Oxidases: Structures, Catalytic Mechanisms and Role in Pathophysiology. Floris G, Mondovì B (Eds). CRC Press, FL, USA 39–50 (2009).
  • Pietrangeli P , MorpurgoL, MondovìB, Di Paolo ML, Rigo A. Soluble Copper amine oxidases from mammals. In: Copper Amine Oxidases: Structures, Catalytic Mechanisms and Role in Pathophysiology. Floris G, Mondovì B (Eds). CRC Press, FL, USA 51–68 (2009).
  • Boyce S , TiptonKF, O‘SullivanMIet al. Nomenclature and potential functions of copper amine oxidases. In: Copper Amine Oxidases: Structures, Catalytic Mechanisms and Role in Pathophysiology. Floris G & Mondovì B (Eds). CRC Press, FL, USA 5–18 (2009).
  • Boomsma F , DerkxFH, van den Meiracker AH, Man in‘t Veld AJ, Schalekamp MA. Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated hemoglobin. Clin. Sci. (Lond.)88, 675–679 (1995).
  • Boomsma F , van den MeirackerAH, WinkelSet al. Circulating semicarbazide-sensitive amine oxidase is raised both in Type I (insulin-dependent), in Type II (non-insulin-dependent) diabetes mellitus and even in childhood Type I diabetes at first clinical diagnosis. Diabetologia42, 233–237 (1999).
  • Garpenstrand H , EkblomJ, BacklundLB, OrelandL, RosenqvistU. Elevated plasma semicarbazide-sensitive amine oxidase (SSAO) activity in Type 2 diabetes mellitus complicated by retinopathy.Diabet. Med.16, 514–521 (1999).
  • Meszaros Z , SzombathyT, RaimondiL, KaradiI, RomicsL, MagyarK. Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: correlation with body mass index and serum triglyceride.Metabolism48, 113–117 (1999).
  • Boomsma F , Pedersen-BjergaardU, Agerholm-LarsenBet al. Association between plasma activities of semicarbazide-sensitive amine oxidase and angiotensin-converting enzyme in patients with Type 1 diabetes mellitus. Diabetologia 48, 1002–1007 (2005).
  • Gokturk C , NordquistJ, SugimotoH, Forsberg-NilssonK, NilssonJ, OrelandL. Semicarbazide-sensitive amine oxidase in transgenic mice with diabetes.Biochem. Biophys. Res. Commun.325, 1013–1020 (2004).
  • Visentin V , BourS, BoucherJet al. Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide. Eur. J. Pharmacol. 522, 139–146 (2005).
  • Somfai GM , KnippelB, RuzicskaEet al. Soluble semicarbazide-sensitive amine oxidase (SSAO) activity is related to oxidative stress and subchronic inflammation in streptozotocin-induced diabetic rats. Neurochem. Int. 48, 746–752 (2006).
  • Cioni L , De SienaG, GhelardiniCet al. Activity and expression of semicarbazide-sensitive benzylamine oxidase in a rodent model of diabetes: interactive effects with methylamine and α-aminoguanidine. Eur. J. Pharmacol.529, 179–187 (2006).
  • Ekblom J . Potential therapeutic value of drugs inhibiting semicarbazide-sensitive amine oxidase: vascular cytoprotection in diabetes mellitus.Pharmacol. Res.37, 87–92 (1998).
  • Mátyus P , Dajka-HalászB, FöldiA, HaiderN, BarloccoD, MagyarK. Semicarbazide-sensitive amine oxidase: current status and perspectives.Curr. Med. Chem.11, 1285–1298 (2004).
  • Yu P , ZuoD. Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications.Diabetologia40, 1243–1250 (1997).
  • Gubisne-Haberlé D , HillW, KazachkovM, RichardsonJS, YuPH. Protein cross-linkage induced by formaldehyde derived from semicarbazide-sensitive amine oxidase-mediated deamination of methylamine.J. Pharmacol. Exp. Ther.310, 1125–1132 (2004).
  • Yu PH , WangM, FanH, DengY, Gubisne-HaberléD. Involvement of SSAO-mediated deamination in adipose glucose transport and weight gain in obese diabetic KKAy mice.Am. J. Physiol. Endocrinol. Metab.286, E634–E641 (2004).
  • Prévot D , SolteszZ, AbelloVet al. Prolonged treatment with aminoguanidine strongly inhibits adipocyte semicarbazide-sensitive amine oxidase and slightly reduces fat deposition in obese Zucker rats. Pharmacol. Res. 56, 70–79 (2007).
  • Masini E , RaimondiL. Pharmacological applications of copper amine oxidases. In: Copper Amine Oxidases: Structures, Catalytic Mechanisms and Role in Pathophysiology. Floris G, Mondovì B (Eds). CRC Press, FL, USA 239–252 (2009).
  • Kazachkov M , ChenK, BabiyS, YuPH. Evidence for in vivo scavenging by aminoguanidine of formaldehyde produced via SSAO-mediated deamination. J. Pharmacol. Exp. Ther.322, 1201–1207 (2007).
  • Yu PH , WangM, DengYL, FanH, Shira-BockL. Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in atherogenesis in KKAy diabetic mice fed with high cholesterol diet.Diabetologia45, 1255–1262 (2002).
  • Mercier N , El HadriK, Osborne-PellegrinMet al. Modifications of arterial phenotype in response to amine oxidase inhibition by semicarbazide. Hypertension50, 234–241 (2007).
  • Mercier N , KakouA, ChallandeP, LacolleyP, Osborne-PellegrinM. Comparison of the effects of semicarbazide and β-aminopropionitrile on the arterial extracellular matrix in the Brown Norway rat.Toxicol. Appl. Pharmacol.239, 258–267 (2009).
  • Carpéné C , BourS, VisentinVet al. Amine oxidase substrates for impaired glucose tolerance correction. J. Physiol. Biochem. 61, 405–420 (2005).
  • Moldes M , FèveB, PairaultJ. Molecular cloning of a major mRNA species in murine 3T3 adipocyte lineage. Differentiation-dependent expression, regulation, and identification as semicarbazide-sensitive amine oxidase.J. Biol. Chem.274, 9515–9523. (1999).
  • Bour S , DaviaudD, GrèsSet al. Adipogenesis-related increase of semicarbazide-sensitive amine oxidase and monoamine oxidase in human adipocytes. Biochimie 89, 916–925 (2007).
  • Morris NJ , DucretA, AebersoldR, RossSA, KellerSR, LienhardGE. Membrane amine oxidase cloning and identification as a major protein in the adipocyte plasma membrane.J. Biol. Chem.272, 9388–9392 (1997).
  • Morin N , LizcanoJM, FontanaEet al. Semicarbazide-sensitive amine oxidase substrates stimulate glucose transport and inhibit lipolysis in human adipocytes. J. Pharmacol. Exp. Ther. 297, 563–572 (2001).
  • Zorzano A , AbellaA, MartiL, CarpénéC, PalacinM, TestarX. Semicarbazide-sensitive amine oxidase activity exerts insulin-like effects on glucose metabolism and insulin-signaling pathways in adipose cells.Biochim. Biophys. Acta1647, 3–9 (2003).
  • Enrique-Tarancon G , CastanI, MorinNet al. Substrates of semicarbazide-sensitive amine oxidase cooperate with vanadate to stimulate tyrosine phosphorylation of IRS proteins, phosphatidylinositol 3-kinase activity and GLUT4 translocation in adipose cells. Biochem. J. 350, 171–180 (2000).
  • Lu B , EnnisD, LaiRet al. Enhanced sensitivity of insulin-resistant adipocytes to vanadate is associated with oxidative stress and decreased reduction of vanadate (±5) to vanadyl (±4). J. Biol. Chem. 276, 35589–35598 (2001).
  • Huyer G , LiuS, KellyJet al. Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. J. Biol. Chem. 272, 843–851 (1997).
  • Shisheva A , ShechterY. Mechanism of pervanadate stimulation and potentiation of insulin-activated glucose transport in rat adipocytes: dissociation from vanadate effect.Endocrinology133, 1562–1568 (1993).
  • Nolte LA , HanDH, HansenPA, HuckerKA, HolloszyJO. A peroxovanadium compound stimulates muscle glucose transport as powerfully as insulin and contractions combined.Diabetes52, 1918–1925 (2003).
  • Abella A , MartiL, CampsMet al. Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 activity exerts an antidiabetic action in Goto–Kakizaki rats. Diabetes 52, 1004–1013 (2003).
  • Marti L , AbellaA, CarpénéC, PalacinM, TestarX, ZorzanoA. Combined treatment with benzylamine and low dosages of vanadate enhances glucose tolerance and reduces hyperglycemia en streptozotocin-induced diabetic rats.Diabetes50, 2061–2068 (2001).
  • Nilsson J , DegermanE, HaukkaMet al. Bis- and tris(pyridyl)amine-oxidovanadium complexes: characteristics and insulin-mimetic potential. Dalton Trans.38, 7902–7911 (2009).
  • Yraola F , Garcia-VicenteS, MartiL, AlbericioF, ZorzanoA, RoyoM. Understanding the mechanism of action of the novel SSAO substrate (C7NH10)6(V10O28).2H2O, a prodrug of peroxovanadate insulin mimetics. Chem. Biol.Drug Des.69, 423–428 (2007).
  • Zorzano A , PalacínM, MartiL, García-VicenteS. Arylalkylamine vanadium salts as new anti-diabetic compounds.J. Inorg. Biochem.103, 559–566 (2009).
  • Soltesz Z , TabiT, HalaszASet al. Studies on the insulinomimetic effects of benzylamine, exogenous substrate of semicarbazide-sensitive amine oxidase enzyme, in streptozotocin induced diabetic rtas. J. Neural Transm. 114, 851–855 (2007).
  • Iffiú-Soltész Z , PrévotD, GrèsSet al. Influence of benzylamine acute and chronic administration of benzylamine on glucose tolerance in diabetic and obese mice fed on very high-fat diet. J. Physiol. Biochem. 63, 305–316 (2007).
  • Iffiú-Soltészv Z , WanecqE, LombaAet al. Chronic benzylamine administration in the drinking water improves glucose tolerance, reduces body weight gain and circulating cholesterol in high-fat diet-fed mice. Pharmacol. Res. 61, 355–363 (2010).
  • El Hadri K , MoldesM, MercierN, AndreaniM, PairaultJ, FèveB. Semicarbazide-sensitive amine oxidase in vascular smooth muscle cells: differentiation-dependent expression and role in glucose uptake.Arterioscler. Thromb. Vasc. Biol.22, 89–94 (2002).
  • Stolen CM , MadanatR, MartiLet al. Semicarbazide sensitive amine oxidase overexpression has dual consequences: insulin mimicry and diabetes-like complications. FASEB J. 18, 702–704 (2004).
  • Boucher J , MasriB, DaviaudDet al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146, 1764–1771 (2005).
  • Yraola F , Garcia-VicenteS, Fernandez-RecioJet al. New efficient substrates for semicarbazide-sensitive amine oxidase/VAP-1 enzyme: analysis by SARs and computational docking. J. Med. Chem. 49, 6197–6208 (2006).
  • Yraola F , ZorzanoA, AlbericioF, RoyoM. Structure–activity relationships of SSAO/VAP-1 arylalkylamine-based substrates.ChemMedChem.4, 495–503 (2009).
  • Bonaiuto E , LunelliM, ScarpaM, VettorR, MilanG, DiPaoloML. A structure–activity study to identify novel and efficient substrates of the human semicarbazide-sensitive amine oxidase/VAP1 enzyme.Biochimie92, 858–868 (2010).
  • Dray C , KnaufC, DaviaudDet al. Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab. 8, 437–445 (2008).
  • Carpéné C , DrayC, AttanéCet al. Expanding role for the apelin/APJ system in physiopathology. J. Physiol. Biochem. 63, 359–374 (2007).
  • Valente T , SoléM, UnzetaM. SSAO/VAP-1 protein expression during mouse embryonic development.Dev. Dyn.237, 2585–2593 (2008).
  • Wanecq E , PrévotD, CarpénéC. Lack of direct insulin-like action of visfatin/Nampt/PBEF1 in human adipocytes.J. Physiol. Biochem.65, 351–360 (2009).
  • Iglesias-Osma MC , Garcia-BarradoMJ, VisentinVet al. Benzylamine exhibits insulin-like effects on glucose disposal, glucose transport, and fat cell lipolysis in rabbits and diabetic mice. J. Pharmacol. Exp. Ther. 309, 1020–1028 (2004).
  • Bour S , VisentinV, PrévotDet al. Effects of oral administration of benzylamine on glucose tolerance and lipid metabolism in rats. J. Physiol. Biochem. 61, 371–379 (2005).
  • Carpéné C . Amine oxidases in adipose tissue-related disorders. In: Copper Amine Oxidases: Structures, Catalytic Mechanisms and Role in Pathophysiology. Floris G, Mondovì B (Eds). CRC Press, FL, USA 177–194 (2009).
  • Hayes GR , LockwoodDH. Role of insulin receptor phosphorylation in the insulinomimetic effects of hydrogen peroxide.Proc. Natl Acad. Sci. USA84, 8115–8119 (1987).
  • Krieger-Brauer HI , MeddaPK, KatherH. Insulin-induced activation of NADPH-dependent H2O2 generation in human adipocyte plasma membranes is mediated by Gai2. J. Biol. Chem.272, 10135–10143 (1997).
  • Mahadev K , ZilberingA, ZhuL, GoldsteinBJ. Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1B in vivo and enhances the early insulin action cascade. J. Biol. Chem.276(24), 21938–61942 (2001).
  • Müller G , WiedS, OverS, FrickW. Inhibition of lipolysis by palmitate, H2O2 and the sulfonylurea drug, glimepiride, in rat adipocytes depends on cAMP degradation by lipid droplets. Biochemistry47, 1259–1273 (2008).
  • Andersen A . Final report on the safety assessment of benzaldehyde.Int. J. Toxicol.25(Suppl. 1), 11–27 (2006).
  • Solé M , Hernandez-GuillamonM, BoadaM, UnzetaM. p53 phosphorylation is involved in vascular cell death induced by the catalytic activity of membrane-bound SSAO/VAP-1.Biochim. Biophys. Acta1783, 1085–1094 (2008).
  • Langford SD , TrentMB, BoorPJ. Cultured rat vascular smooth muscle cells are resistant to methylamine toxicity: no correlation to semicarbazide-sensitive amine oxidase.Cardiovasc. Toxicol.1, 51–60 (2001).
  • Yu PH , ZuoDM. Formaldehyde produced endogenously via deamination of methylamine. A potential risk factor for initiation of endothelial injury.Atherosclerosis120, 189–197 (1996).
  • Dunkel P , GelainA, BarloccoDet al. Semicarbazide-sensitive amine oxidase/vascular adhesion protein 1: recent developments concerning substrates and inhibitors of a promising therapeutic target. Curr. Med. Chem. 15, 1827–1839 (2008).
  • O‘Sullivan M , MacDougallMB, UnzetaM, LizcanoJM, TiptonKF. Semicarbazide-sensitive amine oxidases in pig dental pulp.Biochim. Biophys. Acta.1647, 333–336 (2003).
  • O‘Sullivan J , O‘SullivanM, TiptonKF, UnzetaM, Del Mar Hernandez M, Davey GP. The inhibition of semicarbazide-sensitive amine oxidase by aminohexoses. Biochim. Biophys. Acta.1647, 367–371 (2003).
  • Kankuri E , VaaliK, KnowlesRGet al. Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl)benzyl]acetamidine. J. Pharmacol. Exp. Ther. 298, 1128–1132 (2001).
  • Linscheid P , SeboekD, ZulewskiHet al. Cytokine-induced metabolic effects in human adipocytes are independent of endogenous nitric oxide. Am. J. Physiol. Endocrinol. Metab. 290, E1068–E1077 (2006).
  • Chalon S , TarkiainenJ, GarreauLet al. Pharmacological characterization of N,N-dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a ligand of the serotonin transporter with high affinity and selectivity. J. Pharmacol. Exp. Ther. 304, 81–87 (2003).
  • Jakobsson E , NilssonJ, OggD, KleywegtGJ. Structure of human semicarbazide-sensitive amine oxidase/vascular adhesion protein-1.Acta Crystallogr. D Biol. Crystallogr.61, 1550–1562 (2005).
  • Marti L , AbellaA, De La Cruz X et al. Exploring the binding mode of semicarbazide-sensitive amine oxidase/VAP-1: identification of novel substrates with insulin-like activity. J. Med. Chem.47, 4865–4874 (2004).
  • Gallardo-Godoy A , HernandezM, SanzE, UnzetaM. Synthesis of 4-methyl-thio-phenyl-propylamine and the evaluation of its interaction with different amine oxidases.Bioorg. Med. Chem.12, 273–279 (2004).
  • Wang EY , GaoH, Salter-CidLet al. Design, synthesis, and biological evaluation of semicarbazide-sensitive amine oxidase (SSAO) inhibitors with anti-inflammatory activity. J. Med. Chem. 49, 2166–2173 (2006).
  • Stolen CM , Marttila-IchiharaF, KoskinenKet al. Absence of the endothelial oxidase AOC3 leads to abnormal leukocyte traffic in vivo. Immunity 22, 105–115 (2005).
  • Lino CS , SalesTP, GomesPBet al. Anti-diabetic activity of a fraction from Cissus verticillata and tyramine, its main bioactive constituent, in alloxan-induced diabetic rats. Am. J. Pharmacol. Toxicol. 2, 178–188 (2007).
  • Fontana E , BoucherJ, MartiLet al. Amine oxidase substrates mimic several of the insulin effects on adipocyte differentiation in 3T3 F442A cells. Biochem. J. 356, 769–777 (2001).
  • Carpéné C , DaviaudD, BoucherJet al. Short- and long-term insulin-like effects of monoamine oxidase and semicarbazide-sensitive amine oxidase substrates in cultured adipocytes. Metabolism 55, 1397–1405 (2006).
  • Mercier N , MoldesM, El Hadri K, Fève B. Semicarbazide-sensitive amine oxidase activation promotes adipose conversion of 3T3-L1 cells. Biochem. J.358, 335–342 (2001).
  • Subra C , FontanaE, VisentinV, TestarX, CarpénéC. Tyramine and benzylamine partially but selectively mimic insulin action on adipose differentiation in 3T3-L1 cells.J. Physiol. Biochem.59, 209–216 (2003).
  • Bour S , VisentinV, GrèsS, Saulnier-BlacheJS, WabitschM, CarpénéC. Tyramine, benzylamine, and to a lesser extent histamine, partially mimic the adipogenic effect of insulin in a human preadipocyte cell strain.Inflamm. Res.54(Suppl. 1), S60–S61 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.